Literature DB >> 14996495

Control of mitochondrial permeability by Bcl-2 family members.

Juanita C Sharpe1, Damien Arnoult, Richard J Youle.   

Abstract

Programmed cell death (apoptosis) is regulated by the Bcl-2 family of proteins. Although it remains unclear how these family members control apoptosis, they clearly have the capacity to regulate the permeability of intracellular membranes to ions and proteins. Proapoptotic members of the Bcl-2 family, especially Bax and Bid, have been extensively analyzed for the ability to form channels in membranes and to regulate preexisting channels. Anti-apoptotic members of the family tend to have the opposing effects on membrane channel formation. The molecular mechanisms of the different models for the permeabilization of membranes by the Bcl-2 family members and the regulation of Bcl-2 family member subcellular localizations are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996495     DOI: 10.1016/j.bbamcr.2003.10.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  98 in total

1.  Induction of heat shock protein 70 inhibits ischemic renal injury.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon G B Bonegio; Andrea Havasi; Clayton R Hunt; Michael Y Sherman; John H Schwartz; Steven C Borkan
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

2.  Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax.

Authors:  Zhi Zhang; Suzanne M Lapolla; Matthew G Annis; Mary Truscott; G Jane Roberts; Yiwei Miao; Yuanlong Shao; Chibing Tan; Jun Peng; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

Review 3.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

4.  The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture.

Authors:  Cheng Chang; Youqing Zhu; Xiaoyan Tang; Wenhui Tao
Journal:  Mol Biol Rep       Date:  2010-03-24       Impact factor: 2.316

5.  Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival.

Authors:  Lakshmi R Perumalsamy; Manjula Nagala; Apurva Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-25       Impact factor: 11.205

6.  Bcl-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding.

Authors:  Ting Song; Gaobo Chai; Yubo Liu; Xiaoyan Yu; Ziqian Wang; Zhichao Zhang
Journal:  Br J Pharmacol       Date:  2016-01-16       Impact factor: 8.739

7.  Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation.

Authors:  Ting Song; Peiran Wang; Xiaoyan Yu; Anhui Wang; Gaobo Chai; Yudan Fan; Zhichao Zhang
Journal:  Br J Pharmacol       Date:  2018-12-26       Impact factor: 8.739

8.  Palmitate alters neuregulin signaling and biology in cardiac myocytes.

Authors:  Thomas A Miller; Basak Icli; Gregory M Cote; Nathan K Lebrasseur; Steve C Borkan; David R Pimentel; Xuyang Peng; Douglas B Sawyer
Journal:  Biochem Biophys Res Commun       Date:  2008-12-12       Impact factor: 3.575

9.  Dynamical binding of hydrogen-bond surrogate derived Bak helices to antiapoptotic protein Bcl-xL.

Authors:  Ju Bao; Xiao Y Dong; John Z H Zhang; Paramjit S Arora
Journal:  J Phys Chem B       Date:  2009-03-19       Impact factor: 2.991

10.  Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis.

Authors:  Rana S Moubarak; Victor J Yuste; Cédric Artus; Aïda Bouharrour; Peter A Greer; Josiane Menissier-de Murcia; Santos A Susin
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.